Corruption in the Pharmaceutical Sector-Reference-Cited by-同舟云学术

Corruption in the Pharmaceutical Sector

Published:2017-08-29 Issue: Volume: Page:329-361
ISSN:
Container-title:The Handbook of Business and Corruption
language:
Short-container-title:

Author:

Martinez Martha Gabriela,Kohler Jillian Clare,McAlister Heather

Publisher

Emerald Publishing Limited

Reference45 articles.

1. Industry-Sponsored Clinical Research

2. The $2.6 Billion Pill — Methodologic and Policy Considerations

3. Baghdadi-Sabeti, G. Cohen-Kohler, J. C. & Wondemagegnehu, E. (2009). Measuring transparency in the public pharmaceutical sector: Assessment instrument (p. 196). World Health Organization. Retrieved from http://apps.who.int/medicinedocs/documents/s16732e/s16732e.pdf. Accessed on November 11, 2016.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Availability of essential, generic medicines before and during COVID-19 at selected public pharmaceutical supply agencies in Ethiopia: a comparative cross-sectional study;BMJ Open;2024-03

2. Promoting transparency and accountability towards anti-corruption in pharmaceutical procurement system: does e-procurement play a significant role?;Management Matters;2024-01-03

3. Conclusion;Healthcare Corruption;2024

4. Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region;Globalization and Health;2022-03-18

5. Pharmamarketing, Strafrecht, Selbstregulierung – Einführung in den Band;Institutionelle Korruption und Arzneimittelvertrieb;2018-06-20